Managed by NetworkPharma

Managed by
NetworkPharma

The Publication Plan

WHAT'S THIS?

  • Home
  • About us
  • Email sign up
  • Basics
  • Features
  • Commentary
  • Viewpoints
  • Advertorials
  • Press releases
  • Resources
  • Events
  • Directory
  • Webcasts

  • Join The Publication Plan LinkedIn Group
    Join The Publication Plan LinkedIn Group here.



    This is a freely accessible online resource for everyone involved in publication planning. Help us build the site into a valuable resource for, amongst others, medical writers and communications professionals, pharmaceutical industry managers, medical journal editors and publishers.

    If you have any contributions, ideas, comments about the service or questions about advertising and sponsorship, please contact the Publisher, Peter Llewellyn.

    Managed by NetworkPharma

    Managed by
    NetworkPharma


    Related Sites

    European CME Forum

    KeywordPharma

    MedComms Forum

    MedComms Networking

    ThePharmYard

    RECENT ADDITIONS

    New information that is relevant to publication planning, is constantly being added to this freely accessible resource.

    The latest additions are highlighted below, the rest can be found via the menu on the left. We welcome ideas and contributions from our visitors so please join in and help spread the word.


    Open access publication fees at the BMJ
    Published 17 August 2010

    The BMJ announces they are adopting the "author pays" model for research, but only when funders have pledged to pick up the bill

    [Link to original source material]


    Outcome Reporting Among Drug Trials Registered in ClinicalTrials.gov
    Published 3 August 2010

    A new study in Annals of Internal Medicine suggests that drug studies funded by industry are significantly more likely to have favourable outcomes than those funded by the government or non-profit groups.

    [Link to original source material]


    Don't Mess with the DSMB
    Published 29 July 2010

    Jeffrey M. Drazen, M.D. and Alastair J.J. Wood writing in the NEJM, call for fundamental changes in the way DSMBs (data and safety monitoring boards) are constituted, are funded, and report, regardless of whether there is a commercial or a public sponsor. They propose that to prevent sponsors from interfering with an ongoing study, the trial steering committee would report only to the DSMB.

    [Link to original source material]


    Disclosing Industry Relationships — Toward an Improved Federal Research Policy
    Published 14 July 2010

    Eric G. Campbell and Darren E. Zinner writing in the NEJM, review moves for more stringent requirements for academic researchers to reveal industry payments.

    [Link to original source material]


    An international registry of systematic-review protocols
    Published 13 July 2010

    Alison Booth and colleagues writing in The Lancet, describe how they are developing an international facility to register the details of ongoing systematic reviews in health and social care.

    [Link to original source material]


    Towards more uniform conflict disclosures
    Published 30 June 2010

    The BMJ reports the updated ICMJE conflict of interest reporting form. Note this editorial was published simultaneously in all ICMJE member journals.

    [Link to original source material]


    US senator calls for tougher rules on ghostwriting
    Published 30 June 2010

    The BMJ reports that Senator Charles Grassley and the US Senate Committee on Finance have called for tougher rules and better disclosure about ghostwriting of journal articles. In a report issued on 24 June they have asked medical journals, medical centres, and the US National Institutes of Health (NIH) to impose stricter rules.

    [Link to original source material]


    Managing Financial Conflict of Interest in Biomedical Research
    Published 16 June 2010

    Francis S. Collins, National Institutes of Health, writes in JAMA that as the nation's biomedical research agency, the National Institutes of Health (NIH) must ensure that the research it funds on the behalf of US taxpayers is scientifically rigorous and free of bias. Over the course of more than 65 years and hundreds of thousands of awards, most researchers receiving funds from NIH have proved to be trustworthy stewards. Still, more must be done to retain, and in some instances regain, public trust in the biomedical and behavioral research enterprise.

    [Link to original source material]


    Modified intention to treat reporting in randomised controlled trials: systematic review
    Published 14 June 2010

    An article by Iosief Abraha in the BMJ describes a study to determine the incidence and characteristics of randomised controlled trials that report using the modified intention to treat approach, and how the approach is described.

    [Link to original source material]


    EU drugs agency slammed again over data access
    Published 9 June 2010

    Lynne Taylor reports in PharmaTimes that the European Medicines Agency’s refusal to allow researchers access to trial documents relating to two anti-obesity drugs has been ruled “an instance of maladministration,” by the European Ombudsman.

    [Link to original source material]


    US National Institutes of Health proposes new rules on researchers’ ties to industry
    Published 4 June 2010

    Janice Hopkins Tanne writes in the BMJ that senior figures at the US National Institutes of Health (NIH) have proposed new, stricter rules for funded researchers on showing their ties with industry.

    [Link to original source material]

    LATEST PRESS RELEASES

    ISMPP and MPIP Announce New Medical Publishing Website
    Published 29 July 2010

    From The International Society for Medical Publication Professionals (ISMPP)

    [Access full article here].

    WHAT ELSE?

    NEWS ALERT!

    Do you want to be alerted to important news and events relevant to publication planning?

    Sign up here.


    Dove Press


    MedComms Strategic Forum 2010: Reshaping the healthcare Conversation

    [View details here]

    Strategic Medcomms Forum 2010: Reshaping the healthcare conversation

    30 September 2010
    Oxford University Musuem

    The first of a series of annual events where we consider how the global medical and pharmaceutical industry engages with its stakeholders and we identify and debate future directions and implications for medical-marketing activity.

    [View details here]

    Organized by NetworkPharma.


    Getting research published: an A to Z of publication strategy, 2nd Edition

    This web site and associated activities are being managed by NetworkPharma Ltd, 89 Oxford Road, Oxford, OX2 9PD, UK
    Telephone +44 (0) 1865 865943 Email: support@networkpharma.com

    Other services managed by NetworkPharma
    [www.EuropeanCMEforum.eu] [www.KeywordPharma.com] [www.MedCommsForum.com] [www.MedCommsNetworking.co.uk]
    [www.NetworkPharma.tv] [www.ThePharmYard.com]